Applying drug-eluting stents in clinical practice
- PMID: 17719350
- DOI: 10.1016/j.amjcard.2007.06.005
Applying drug-eluting stents in clinical practice
Abstract
The use of percutaneous coronary interventions has resulted in significant improvement in patient care; however, the risk for restenosis remains a major limitation. Drug-eluting stents represent an impressive breakthrough in the evolution of interventional cardiology, but it is important to understand the limits to their added benefit. Safety of the procedure must continue to be the first consideration, and technique must not be compromised to accommodate new technology.
Similar articles
-
Understanding the drug-eluting stent trials.Am J Cardiol. 2007 Sep 3;100(5A):17K-24K. doi: 10.1016/j.amjcard.2007.06.004. Epub 2007 Jun 26. Am J Cardiol. 2007. PMID: 17719349 Review.
-
Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.J Invasive Cardiol. 2006 Jun;18(6):E166-8. J Invasive Cardiol. 2006. PMID: 16775892 No abstract available.
-
[Percutaneous coronary intervention].Orv Hetil. 2005 Mar 27;146(13):587-93. Orv Hetil. 2005. PMID: 15856622 Review. Hungarian.
-
Cardiology patient page. Drug-eluting stents.Circulation. 2007 May 1;115(17):e426-7. doi: 10.1161/CIRCULATIONAHA.107.688176. Circulation. 2007. PMID: 17470700 No abstract available.
-
Efficacy and safety of drug-eluting stents: current best available evidence.J Card Surg. 2006 Nov-Dec;21(6):605-12; discussion 613-4. doi: 10.1111/j.1540-8191.2006.00325.x. J Card Surg. 2006. PMID: 17073969 Review.
Cited by
-
Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents.Angiol Open Access. 2013;1(2):109. doi: 10.4172/2329-9495.1000109. Angiol Open Access. 2013. PMID: 26225356 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical